WellNow Clinical Research Pediatric Migraine Study


This initiative encompasses two different migraine studies focused on the pediatric target population. This study will evaluate the effectiveness of a medication already approved for treating adult migraine attacks. For this study, we will enroll adolescents that are experiencing 1-8 migraine attacks in a one-month period. One study is shorter with a 19-week timespan with 4 study appointments, while the second study will last 58 weeks with 13 office visits.  

Qualified Participants are: 

  • Between 12-17 years of age 

  • Must have 1-8 migraines per month on average. 


10575 Springfield Ave, Suite A

Cincinnati, Ohio 45215

(513) 978-5070

Pediatric Migraine Study - Cincinnati

WellNow Urgent Care & Research partners with multinational pharmaceuticals, biotechnology companies, medical device manufacturers & CROs to help drive improvements to health and well-being. In our 15 years of research, WellNow has had over 17,000 visits to our network of clinical research sites.
Facebook for wellnow research
Youtube for WN research
Twitter for WN Research